Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile
Neeraj Agarwal, MD, FASCO

@neerajaiims

Medical Oncologist. Editor-in-chief: @ASCO Daily News; Presidential Endowed Chair, @HuntsmanCancer (NCI-CCC) @UUtah, FCOI bit.ly/3A3u2KL

ID: 4761682514

linkhttps://bit.ly/3JApRJd calendar_today15-01-2016 06:32:10

13,13K Tweet

15,15K Takipçi

770 Takip Edilen

Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile Photo

Breaking news ASCO #ASCO25 👉 1st biomarker selected, positive ph3 trial in mHSPC #ProstateCancer 👉Abiraterone+ niraparib/PARPi significant improve rPFS (favorable OS trend) in HRR+ pts (⬆️benefit in BRCApts), NGS testing must inall AttardLab PCF Science UroToday.com OncoAlert

Breaking news <a href="/ASCO/">ASCO</a> #ASCO25 👉 1st biomarker selected, positive ph3 trial in mHSPC #ProstateCancer 👉Abiraterone+ niraparib/PARPi significant improve rPFS (favorable OS trend) in HRR+ pts (⬆️benefit in BRCApts), NGS testing must inall <a href="/AttardLab/">AttardLab</a> <a href="/PCF_Science/">PCF Science</a> <a href="/urotoday/">UroToday.com</a> <a href="/OncoAlert/">OncoAlert</a>